{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T02:20:27Z","timestamp":1787624427027,"version":"build-2736575974"},"reference-count":42,"publisher":"Springer Science and Business Media LLC","issue":"11","license":[{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmiedeberg's Arch Pharmacol"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1007\/s00210-026-05479-3","type":"journal-article","created":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T02:55:11Z","timestamp":1779764111000},"page":"17613-17633","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Quality by design based development and optimization of a thermoreversible in situ intranasal gel of zavegepant for nose to brain delivery in migraine therapy"],"prefix":"10.1007","volume":"399","author":[{"given":"Anil","family":"Pawar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-5286-4030","authenticated-orcid":false,"given":"Vishal","family":"Balme","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramdas","family":"Pandhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinayak","family":"Deshmukh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Babasaheb","family":"Bhagat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santosh","family":"Belhekar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0007-4782-1614","authenticated-orcid":false,"given":"Vaibhav","family":"Andhale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,26]]},"reference":[{"key":"5479_CR1","doi-asserted-by":"publisher","first-page":"32","DOI":"10.31351\/vol31issSuppl.pp32-44","volume":"31","author":"A Alabdly","year":"2022","unstructured":"Alabdly A, Kassab HJ (2022) Formulation variables effect on gelation temperature of nefopam hydrochloride intranasal in situ gel (Conference paper) #. Iraqi J Pharm Sci 31:32\u201344. https:\/\/doi.org\/10.31351\/vol31issSuppl.pp32-44","journal-title":"Iraqi J Pharm Sci"},{"key":"5479_CR2","doi-asserted-by":"publisher","first-page":"32","DOI":"10.31351\/vol31issSuppl.pp32-44","volume":"31","author":"A Alabdly","year":"2023","unstructured":"Alabdly A, Kassab JH (2023) Formulation variables effect on gelation temperature of nefopam hydrochloride intranasal in situ gel (Conference paper) #. IJPS 31:32\u201344. https:\/\/doi.org\/10.31351\/vol31issSuppl.pp32-44","journal-title":"IJPS"},{"key":"5479_CR3","doi-asserted-by":"publisher","DOI":"10.3390\/polym16233422","volume":"16","author":"A Alshraim","year":"2024","unstructured":"Alshraim A, Alshora D, Ashri L, Alhusaini A, Alanazi N, Safwan NM (2024) In situ thermosensitive mucoadhesive nasal gel containing sumatriptan: in vitro and ex vivo evaluations. Polymers Basel 16:3422. https:\/\/doi.org\/10.3390\/polym16233422","journal-title":"Polymers Basel"},{"key":"5479_CR4","doi-asserted-by":"publisher","first-page":"2673","DOI":"10.1208\/s12249-017-0747-8","volume":"18","author":"E Altunta\u015f","year":"2017","unstructured":"Altunta\u015f E, Yener G (2017) Formulation and evaluation of thermoreversible in situ nasal gels containing mometasone furoate for allergic rhinitis. AAPS PharmSciTech 18:2673\u20132682. https:\/\/doi.org\/10.1208\/s12249-017-0747-8","journal-title":"AAPS PharmSciTech"},{"key":"5479_CR5","doi-asserted-by":"publisher","DOI":"10.3389\/fneur.2021.800605","author":"P Amiri","year":"2022","unstructured":"Amiri P, Kazeminasab S, Nejadghaderi SA, Mohammadinasab R, Pourfathi H, Araj-Khodaei M et al (2022) Migraine: a review on its history, global epidemiology, risk factors, and comorbidities. Front Neurol. https:\/\/doi.org\/10.3389\/fneur.2021.800605","journal-title":"Front Neurol"},{"key":"5479_CR6","doi-asserted-by":"publisher","first-page":"1485","DOI":"10.1016\/S0140-6736(20)32160-7","volume":"397","author":"M Ashina","year":"2021","unstructured":"Ashina M, Katsarava Z, Do TP, Buse DC, Pozo-Rosich P, \u00d6zge A et al (2021) Migraine: epidemiology and systems of care. Lancet 397:1485\u20131495. https:\/\/doi.org\/10.1016\/S0140-6736(20)32160-7","journal-title":"Lancet"},{"key":"5479_CR7","doi-asserted-by":"publisher","first-page":"2552","DOI":"10.1016\/j.xphs.2022.04.011","volume":"111","author":"L Bai","year":"2022","unstructured":"Bai L, Lei F, Luo R, Fei Q, Zheng Z, He N et al (2022) Development of a thermosensitive in-situ gel formulations of vancomycin hydrochloride: design, preparation, in vitro and in vivo evaluation. J Pharm Sci 111:2552\u20132561. https:\/\/doi.org\/10.1016\/j.xphs.2022.04.011","journal-title":"J Pharm Sci"},{"key":"5479_CR8","doi-asserted-by":"publisher","first-page":"385","DOI":"10.1080\/05704928.2024.2438747","volume":"60","author":"AA Bunaciu","year":"2025","unstructured":"Bunaciu AA, Hoang VD, Aboul-Enein HY (2025) Fourier transform infrared spectroscopy used in drug excipients compatibility studies. Appl Spectrosc Rev 60:385\u2013403. https:\/\/doi.org\/10.1080\/05704928.2024.2438747","journal-title":"Appl Spectrosc Rev"},{"key":"5479_CR9","doi-asserted-by":"publisher","unstructured":"Chattopadhyay S, Das S, Sarma KN (2021) Nose-to-brain drug delivery: an update to the alternative path to successful targeted anti-migraine drugs. Int J App Pharm 13(2):67\u201375. https:\/\/doi.org\/10.22159\/ijap.2021v13i2.40404","DOI":"10.22159\/ijap.2021v13i2.40404"},{"key":"5479_CR10","doi-asserted-by":"publisher","DOI":"10.3390\/ma14164522","volume":"14","author":"Y Chen","year":"2021","unstructured":"Chen Y, Lee J-H, Meng M, Cui N, Dai C-Y, Jia Q et al (2021) An overview on thermosensitive oral gel based on Poloxamer 407. Materials Basel 14:4522. https:\/\/doi.org\/10.3390\/ma14164522","journal-title":"Materials Basel"},{"key":"5479_CR11","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2024.105988","volume":"99","author":"P Chomchalao","year":"2024","unstructured":"Chomchalao P, Saelim N, Lamlertthon S, Sisopa P, Tiyaboonchai W (2024) A potential thermosensitive poloxamer 407-based in situ hydrogel containing moxifloxacin-loaded silk fibroin nanoparticles for prolonged ocular delivery. J Drug Deliv Sci Technol 99:105988. https:\/\/doi.org\/10.1016\/j.jddst.2024.105988","journal-title":"J Drug Deliv Sci Technol"},{"key":"5479_CR12","doi-asserted-by":"publisher","first-page":"3298","DOI":"10.1021\/acs.molpharmaceut.3c00195","volume":"20","author":"I De Hoon","year":"2023","unstructured":"De Hoon I, Boukherroub R, De Smedt SC, Szunerits S, Sauvage F (2023) In vitro and ex vivo models for assessing drug permeation across the cornea. Mol Pharm 20:3298\u20133319. https:\/\/doi.org\/10.1021\/acs.molpharmaceut.3c00195","journal-title":"Mol Pharm"},{"key":"5479_CR13","doi-asserted-by":"publisher","first-page":"297","DOI":"10.1007\/s40122-024-00690-7","volume":"14","author":"L Dong","year":"2025","unstructured":"Dong L, Dong W, Jin Y, Jiang Y, Li Z, Yu D (2025) The global burden of migraine: a 30-year trend review and future projections by age, sex, country, and region. Pain Ther 14:297\u2013315. https:\/\/doi.org\/10.1007\/s40122-024-00690-7","journal-title":"Pain Ther"},{"key":"5479_CR14","doi-asserted-by":"publisher","first-page":"1131","DOI":"10.1080\/14737175.2024.2405741","volume":"24","author":"G Greco","year":"2024","unstructured":"Greco G, Monteith T (2024) Intranasal zavegepant for the acute treatment of migraine. Expert Rev Neurother 24:1131\u20131140. https:\/\/doi.org\/10.1080\/14737175.2024.2405741","journal-title":"Expert Rev Neurother"},{"key":"5479_CR15","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14040747","volume":"14","author":"V Gugleva","year":"2022","unstructured":"Gugleva V, Michailova V, Mihaylova R, Momekov G, Zaharieva MM, Najdenski H et al (2022) Formulation and evaluation of hybrid niosomal in situ gel for intravesical co-delivery of curcumin and gentamicin sulfate. Pharmaceutics 14:747. https:\/\/doi.org\/10.3390\/pharmaceutics14040747","journal-title":"Pharmaceutics"},{"key":"5479_CR16","doi-asserted-by":"publisher","DOI":"10.3390\/polym14091836","volume":"14","author":"N Hirun","year":"2022","unstructured":"Hirun N, Kraisit P, Tantishaiyakul V (2022) Thermosensitive polymer blend composed of Poloxamer 407, Poloxamer 188 and Polycarbophil for the use as mucoadhesive in situ gel. Polymers Basel 14:1836. https:\/\/doi.org\/10.3390\/polym14091836","journal-title":"Polymers Basel"},{"key":"5479_CR17","first-page":"96","volume":"4","author":"J Jaiswal","year":"2012","unstructured":"Jaiswal J, Anantvar SP, Narkhede MR, Gore SV, Mehta K (2012) Formulation and evaluation of thermoreversible in-situ nasal gel of metoprolol succinate. Int J Pharm Pharm Sci 4:96\u2013102","journal-title":"Int J Pharm Pharm Sci"},{"key":"5479_CR18","doi-asserted-by":"publisher","first-page":"2229","DOI":"10.1080\/10717544.2021.1992040","volume":"28","author":"AK Kammoun","year":"2021","unstructured":"Kammoun AK, Khedr A, Hegazy MA, Almalki AJ, Hosny KM, Abualsunun WA et al (2021) Formulation, optimization, and nephrotoxicity evaluation of an antifungal in situ nasal gel loaded with voriconazole\u2012clove oil transferosomal nanoparticles. Drug Deliv 28:2229\u20132240. https:\/\/doi.org\/10.1080\/10717544.2021.1992040","journal-title":"Drug Deliv"},{"key":"5479_CR19","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1177\/03331024211050036","volume":"42","author":"L Kang","year":"2022","unstructured":"Kang L, Tang W, Zhang Y, Zhang M, Liu J, Li Y et al (2022) The gut microbiome modulates nitroglycerin-induced migraine-related hyperalgesia in mice. Cephalalgia 42:490\u2013499. https:\/\/doi.org\/10.1177\/03331024211050036","journal-title":"Cephalalgia"},{"key":"5479_CR20","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1016\/S1474-4422(22)00517-8","volume":"22","author":"RB Lipton","year":"2023","unstructured":"Lipton RB, Croop R, Stock DA, Madonia J, Forshaw M, Lovegren M et al (2023) Safety, tolerability, and efficacy of zavegepant 10 mg nasal spray for the acute treatment of migraine in the USA: a phase 3, double-blind, randomised, placebo-controlled multicentre trial. Lancet Neurol 22:209\u2013217. https:\/\/doi.org\/10.1016\/S1474-4422(22)00517-8","journal-title":"Lancet Neurol"},{"key":"5479_CR21","doi-asserted-by":"publisher","first-page":"5782","DOI":"10.37285\/ijpsn.2022.15.1.6","volume":"15","author":"V Malviya","year":"2022","unstructured":"Malviya V (2022) Design and characterization of thermosensitive mucoadhesive nasal gel for meclizine hydrochloride: thermosensitive nala gel of meclizine HCL. International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN) 15:5782\u20135793. https:\/\/doi.org\/10.37285\/ijpsn.2022.15.1.6","journal-title":"International Journal of Pharmaceutical Sciences and Nanotechnology(IJPSN)"},{"key":"5479_CR22","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1208\/s12249-024-02870-2","volume":"25","author":"SD Mankar","year":"2024","unstructured":"Mankar SD, Parjane SR, Siddheshwar SS, Dighe SB (2024) Formulation, optimization and in-vivo characterization of thermosensitive in-situ nasal gel loaded with bacoside a for treatment of epilepsy. AAPS PharmSciTech 25:151. https:\/\/doi.org\/10.1208\/s12249-024-02870-2","journal-title":"AAPS PharmSciTech"},{"key":"5479_CR23","doi-asserted-by":"publisher","first-page":"1857","DOI":"10.1080\/03639045.2018.1504059","volume":"44","author":"MA Marzouk","year":"2018","unstructured":"Marzouk MA, Osman DA, Abd El-Fattah AI (2018) Formulation and in vitro evaluation of a thermoreversible mucoadhesive nasal gel of itopride hydrochloride. Drug Dev Ind Pharm 44:1857\u20131867. https:\/\/doi.org\/10.1080\/03639045.2018.1504059","journal-title":"Drug Dev Ind Pharm"},{"key":"5479_CR24","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1089\/adt.2022.044","volume":"20","author":"D Mathure","year":"2022","unstructured":"Mathure D, Ranpise H, Awasthi R, Pawar A (2022) Formulation and characterization of nanostructured lipid carriers of rizatriptan benzoate-loaded in situ nasal gel for brain targeting. ASSAY Drug Dev Technol 20:211\u2013224. https:\/\/doi.org\/10.1089\/adt.2022.044","journal-title":"ASSAY Drug Dev Technol"},{"key":"5479_CR25","doi-asserted-by":"publisher","DOI":"10.3390\/ijms25073706","volume":"25","author":"S Park","year":"2024","unstructured":"Park S, Jung H, Han S-W, Lee S-H, Sohn J-H (2024) Differences in neuropathology between nitroglycerin-induced mouse models of episodic and chronic migraine. Int J Mol Sci 25:3706. https:\/\/doi.org\/10.3390\/ijms25073706","journal-title":"Int J Mol Sci"},{"key":"5479_CR26","doi-asserted-by":"publisher","first-page":"279","DOI":"10.1080\/17581869.2025.2494494","volume":"15","author":"L Pellesi","year":"2025","unstructured":"Pellesi L, Jedie B, Barhum F, Al-Abdullah S, Martelletti P, Xiao Z (2025) Head-to-head relief: ubrogepant, rimegepant, and zavegepant in migraine treatment. Pain Manag 15:279\u2013284. https:\/\/doi.org\/10.1080\/17581869.2025.2494494","journal-title":"Pain Manag"},{"key":"5479_CR27","doi-asserted-by":"publisher","DOI":"10.1177\/03331024241267309","volume":"44","author":"MFP Peres","year":"2024","unstructured":"Peres MFP, Sacco S, Pozo-Rosich P, Tassorelli C, Ahmed F, Burstein R et al (2024) Migraine is the most disabling neurological disease among children and adolescents, and second after stroke among adults: a call to action. Cephalalgia 44:03331024241267309. https:\/\/doi.org\/10.1177\/03331024241267309","journal-title":"Cephalalgia"},{"key":"5479_CR28","doi-asserted-by":"publisher","first-page":"768","DOI":"10.1007\/s12247-023-09762-1","volume":"18","author":"HK Polat","year":"2023","unstructured":"Polat HK, Arslan A, \u00dcnal S, Haydar MK, Aytekin E, G\u00f6zc\u00fc S et al (2023) Formulation development of dual drug-loaded thermosensitive ocular in situ gel using factorial design. J Pharm Innov 18:768\u2013788. https:\/\/doi.org\/10.1007\/s12247-023-09762-1","journal-title":"J Pharm Innov"},{"key":"5479_CR29","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s12247-019-09422-3","volume":"16","author":"M Raval","year":"2021","unstructured":"Raval M, Bagada H (2021) Formulation and evaluation of cyclodextrin-based thermosensitive in situ gel of azithromycin for periodontal delivery. J Pharm Innov 16:67\u201384. https:\/\/doi.org\/10.1007\/s12247-019-09422-3","journal-title":"J Pharm Innov"},{"key":"5479_CR30","doi-asserted-by":"publisher","first-page":"845","DOI":"10.1007\/s10973-022-11849-9","volume":"148","author":"B Rojek","year":"2023","unstructured":"Rojek B, Wesolowski M (2023) A combined differential scanning calorimetry and thermogravimetry approach for the effective assessment of drug substance-excipient compatibility. J Therm Anal Calorim 148:845\u2013858. https:\/\/doi.org\/10.1007\/s10973-022-11849-9","journal-title":"J Therm Anal Calorim"},{"key":"5479_CR31","doi-asserted-by":"publisher","DOI":"10.1097\/j.pain.0000000000002275","volume":"163","author":"S Safiri","year":"2022","unstructured":"Safiri S, Pourfathi H, Eagan A, Mansournia MA, Khodayari MT, Sullman MJM et al (2022) Global, regional, and national burden of migraine in 204 countries and territories, 1990 to 2019. Pain 163:e293. https:\/\/doi.org\/10.1097\/j.pain.0000000000002275","journal-title":"Pain"},{"key":"5479_CR32","doi-asserted-by":"publisher","first-page":"3083","DOI":"10.1007\/s13346-022-01172-z","volume":"12","author":"HF Salem","year":"2022","unstructured":"Salem HF, Ali AA, Rabea YK, El-Ela FIA, Khallaf RA (2022) Glycerosomal thermosensitive in situ gel of duloxetine HCl as a novel nanoplatform for rectal delivery: In vitro optimization and in vivo appraisal. Drug Deliv Transl Res 12:3083\u20133103. https:\/\/doi.org\/10.1007\/s13346-022-01172-z","journal-title":"Drug Deliv Transl Res"},{"key":"5479_CR33","unstructured":"Salih OS, Ghareeb MM (2021) Formulation and in-vitro evaluation of thermosensitive ciprofloxacin HCL in-situ gel for local nasal infection. IJDDT 11(4):1295\u2013301"},{"key":"5479_CR34","doi-asserted-by":"publisher","DOI":"10.1016\/j.jddst.2022.103736","volume":"76","author":"L Shaghlil","year":"2022","unstructured":"Shaghlil L, Alshishani A, Sa\u2019aleek AA, Abdelkader H, Al-ebini Y (2022) Formulation and evaluation of nasal insert for nose-to-brain drug delivery of rivastigmine tartrate. J Drug Deliv Sci Technol 76:103736. https:\/\/doi.org\/10.1016\/j.jddst.2022.103736","journal-title":"J Drug Deliv Sci Technol"},{"key":"5479_CR35","doi-asserted-by":"publisher","first-page":"109","DOI":"10.1038\/s41582-022-00763-1","volume":"19","author":"TJ Steiner","year":"2023","unstructured":"Steiner TJ, Stovner LJ (2023) Global epidemiology of migraine and its implications for public health and health policy. Nat Rev Neurol 19:109\u2013117. https:\/\/doi.org\/10.1038\/s41582-022-00763-1","journal-title":"Nat Rev Neurol"},{"key":"5479_CR36","doi-asserted-by":"publisher","DOI":"10.1016\/j.rechem.2023.101010","volume":"6","author":"K Suhagiya","year":"2023","unstructured":"Suhagiya K, Borkhataria CH, Gohil S, Manek RA, Patel KA, Patel NK et al (2023) Development of mucoadhesive in-situ nasal gel formulation for enhanced bioavailability and efficacy of rizatriptan in migraine treatment. Results Chem 6:101010. https:\/\/doi.org\/10.1016\/j.rechem.2023.101010","journal-title":"Results Chem"},{"key":"5479_CR37","doi-asserted-by":"publisher","first-page":"144","DOI":"10.2174\/1567201819666220401091632","volume":"20","author":"V Tanna","year":"2023","unstructured":"Tanna V, Sawarkar SP, Ravikumar P (2023) Exploring nose to brain nano delivery for effective management of migraine. Curr Drug Deliv 20:144\u2013157. https:\/\/doi.org\/10.2174\/1567201819666220401091632","journal-title":"Curr Drug Deliv"},{"key":"5479_CR38","doi-asserted-by":"publisher","first-page":"49","DOI":"10.31838\/ijprt\/09.02.03","volume":"9","author":"K Trupa","year":"2019","unstructured":"Trupa K, Gandhi S, Nidhi P, Dhruvisha C, Kadiya MJ (2019) Formulation and evaluation nasal in situgel of rizatriptan. International Journal of Pharmacy Research & Technology (IJPRT) 9:49\u201364. https:\/\/doi.org\/10.31838\/ijprt\/09.02.03","journal-title":"International Journal of Pharmacy Research & Technology (IJPRT)"},{"key":"5479_CR39","doi-asserted-by":"publisher","first-page":"308","DOI":"10.1038\/s41401-022-00941-3","volume":"44","author":"D Yang","year":"2023","unstructured":"Yang D, Gao Y, Yin Z, Wang X, Meng X, Zou T et al (2023) Roxadustat alleviates nitroglycerin-induced migraine in mice by regulating HIF-1\u03b1\/NF-\u03baB\/inflammation pathway. Acta Pharmacol Sin 44:308\u2013320. https:\/\/doi.org\/10.1038\/s41401-022-00941-3","journal-title":"Acta Pharmacol Sin"},{"key":"5479_CR40","doi-asserted-by":"publisher","first-page":"274","DOI":"10.34172\/PS.2024.2","volume":"30","author":"A Zarghampour","year":"2024","unstructured":"Zarghampour A, Jouyban K, Jouyban-Gharamaleki V, Jouyban A, Rahimpour E (2024) A description on the shake-flask and laser monitoring-based techniques for determination of the drug\u2019s solubility. Pharm Sci 30:274\u2013278. https:\/\/doi.org\/10.34172\/PS.2024.2","journal-title":"Pharm Sci"},{"key":"5479_CR41","doi-asserted-by":"publisher","DOI":"10.3390\/pharmaceutics14091934","volume":"14","author":"Y Zhao","year":"2022","unstructured":"Zhao Y, Wang T, Chen Z, Ren H, Song P, Zhu Y et al (2022) Development and evaluation of a thermosensitive in situ gel formulation for intravaginal delivery of Lactobacillus gasseri. Pharmaceutics 14:1934. https:\/\/doi.org\/10.3390\/pharmaceutics14091934","journal-title":"Pharmaceutics"},{"key":"5479_CR42","doi-asserted-by":"publisher","DOI":"10.1186\/s10194-025-01984-7","volume":"26","author":"Z Zhu","year":"2025","unstructured":"Zhu Z, Tang Y, Li L, Ni H, Liu M, Chen Z et al (2025) The efficacy and safety of zavegepant nasal inhalation versus oral calcitonin-gene related peptide receptor antagonists in the acute treatment of migraine: a systematic review and network meta-analysis of the literature. J Headache Pain 26:48. https:\/\/doi.org\/10.1186\/s10194-025-01984-7","journal-title":"J Headache Pain"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00210-026-05479-3","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-026-05479-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T01:23:41Z","timestamp":1787621021000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00210-026-05479-3"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,26]]},"references-count":42,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["5479"],"URL":"https:\/\/doi.org\/10.1007\/s00210-026-05479-3","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,26]]},"assertion":[{"value":"3 March 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"26 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Conflict of interest","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was conducted after obtaining approval from the Institutional Animal Ethics Committee (IAEC) (Approval No.: MESCOP\/IAEC\/2023\u201324\/01), and all experimental procedures were performed in accordance with the guidelines of the Committee for Control and Supervision of Experiments on Animals (CCSEA).","order":2,"name":"Ethics","label":"Research involving humans and animals statement","group":{"name":"EthicsHeading","label":"Declarations"}}]}}